Clinical Trials Directory

Trials / Unknown

UnknownNCT06150859

Ayahuasca Assisted Psychotherapy for Grief

Efficacy of Ayahuasca in Concert With Psychotherapy to Decrease the Severity of Grief

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Beckley Med Foundation · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to compare the effectiveness of an ayahuasca-assisted constructivist therapy with constructivist therapy and no treatment to decrease the severity of grief. A secondary purpose is to assess the effectiveness to prevent Persistent Complex Bereavement Disorder and Prolonged Grief Disorder, and to assess potential changes in avoidance, meaning-making and self-clarity. Subjective effects and Acceptance promoting effects of psychedelic drug are assessed after ayahuasca administration. A non-randomized controlled trial is proposed with three arms involving an experimental group (ayahuasca in concert with psychotherapy) and two control groups (psychotherapy and no treatment) with pretest, posttest and 3 months follow-up.

Detailed description

Grief is a deep and intense sorrow caused by the loss of someone loved. Although every person could benefit from support, only a substantial minority of bereaved people experience severe, persistent and disabling grief (PCBD), requiring treatment one year after the death of a loved one. However, pharmacotherapy alone has not proven to be effective, and while psychological interventions for prolonged grief disorder may be efficacious, the clinical effectiveness is small (Hedges' g: 0.41-0.45). As far as we know, no bereavement prevention program has proven to be effective, and early interventions are discouraged. Thus, there are no effective resources for supporting the bereaved during the months following the death of a loved one, a need which peaks during the months following the death, when grief is most intense and the bereaved lives are at their highest level of risk.

Conditions

Interventions

TypeNameDescription
DRUGAyahausca-Assisted psychotherapyDrug: Two ayahuasca administrations (0.75 mg/kg DMT), after 3rd and 6th therapeutic session. Ayahuasca is a psychoactive mixture of plants which contains DMT as an active principle. Constructivist Psychotherapy will be delivered over 9 online psychotherapeutic sessions.
BEHAVIORALConstructivist PsychotherapyConstructivist Psychotherapy will be delivered over 9 online psychotherapeutic sessions
OTHERNo treatmentNo treatment during the control period

Timeline

Start date
2021-10-15
Primary completion
2024-04-15
Completion
2024-06-15
First posted
2023-11-29
Last updated
2023-12-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06150859. Inclusion in this directory is not an endorsement.